Calypte Biomedical Corp (fka CBMC)

[cal_pn]

Hey folks,
an update about the AMEX issue was just published by the company:

http://biz.yahoo.com/prnews/060216/nyth015.html?.v=43

There will be a meeting with the AMEX people at March 13. "If its common stock is delisted from the Exchange after the hearing, it would likely trade on the NASD Over the Counter Bulletin Board." This sounds like the outcome will be decided at March 13. The company will be listed at AMEX until then. I don't know when a potential negative outcome would be executed: Right after the meeting or end of the year (after the earlier 18 months period)?

My personal opinion is that AMEX listing shouldn't change the situation dramatically. We need full China approval (the sooner the better) and we will be fine. If approval in China occurs I think it is getting really evident that the company will make it finally. Sales in China will be a different situation even when compared with Africa. I guess a lot of African clinics have established supply channels in terms of HIV tests so it is not very easy to break into this established relations these days. China might be different because most of the regions have no HIV testing seen so far and the medical infrastructure might be even worse than in Africa (which makes an oral test even more attractive).

Oral test is ideal for mass testings done in the country far away from hospitals.

Also, there was a Medmira deal announced recently about several millions. Nice for Medmira. But Calypte is now a very lean company so just one deal of similiar size for Calypte changes even a lot here (together with ongoing BED sales).

Cal